Increased dosing required for patients with Myasthenia gravis due to the destruction of nicotinic receptors from auto-antibodies *
Anestheia literature supports increased dose of 2.0mg/kg
There is no evidence to support claims of increased hyperkalemia
If the patient is on a cholinesterase inhibitor there will be prolonged effect of the paralytic.
Succinylcholine
Edrophonium
Rocuronium
Pancuronium
Thiopental
Cisatricurium
Etomidate
Vecuronium